0
  • Notifications
  • No notifications yet

  • View All Notifications
ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Y Trap Enters Collaboration With Merck Kgaato Develop Novel Antibody Ligand Traps For Immuno Oncology
News Feed
course image
  • 12 Oct 2019
  • Admin
  • News Article

Y-Trap Enters Collaboration With Merck Kgaa,To Develop Novel Antibody-Ligand Traps For Immuno-Oncology

Y-Trap, Inc. Has Signed A Collaboration And License Agreement With Merck Kgaa, Darmstadt, Germany, A Leading Science And Technology Company, For The Exclusive Development Of Multiple Specific Antibody-Ligand Traps For Cancer Immunotherapy.The Collaboration Leverages Y-Trap'S Proprietary Platform Of Multifunctional Antibody-Ligand Traps For Immuno-Oncology. The Y-Trap Platform Exploits Combinatorial Protein Engineering To Counteract Key Determinants Of Immune Dysfunction In The Tumor Microenvironment. Y-Trap And Merck Kgaa, Darmstadt, Germany, Will Collaborate To Explore The Pharmacology Of Y-Trap Multifunctional Proteins And Merck Kgaa, Darmstadt, Germany, Will Be Responsible For All Development, Manufacturing And Commercialization Activities.Under The Agreement, Merck Kgaa, Darmstadt, Germany, Will Provide Y-Trap With An Upfront Payment In Addition To Milestone Payments And Royalties Based On The Achievement Of Specific Pre-Clinical, Clinical Development, Regulatory, And Commercial Milestones."Cancers Evolve To Counteract And Defeat Immune Surveillance By Co-Opting And Amplifying Natural Mechanisms Of Immune Suppression," Said Atul Bedi, Md, Mba, Co-Founder And Chief Scientist Of Y-Trap, Inc. "Y-Trap'S Multifunctional Antibody-Ligand Traps Are Designed To Counteract Key Determinants Of Immune Tolerance To Entrain More Effective Antitumor Immunity. We Look Forward To Dovetailing The Respective Strengths Of Y-Trap And Merck Kgaa, Darmstadt, Germany, To Advance The Development Of Multiple Molecules From This Platform For Cancer Immunotherapy."

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form